![]() |
市场调查报告书
商品编码
1914095
静脉通路装置市场规模、份额和成长分析(按产品、应用和地区划分)-2026-2033年产业预测Vascular Access Device Market Size, Share, and Growth Analysis, By Product (Short Peripheral Intravenous Catheter, Huber Needles), By End Use (Hospitals, Ambulatory care centers), By Region - Industry Forecast 2026-2033 |
||||||
全球静脉通路装置市场规模预计在 2024 年达到 92.8 亿美元,从 2025 年的 97.8 亿美元增长到 2033 年的 148.9 亿美元,在预测期(2026-2033 年)内复合年增长率为 5.4%。
全球静脉通路装置市场的主要驱动力是癌症、糖尿病、肾臟病和心血管疾病等慢性病的日益增多。这些疾病需要长期治疗,例如化疗和透析。人口老化和生活方式的改变导致慢性病发病率上升,进而推动了对耐用静脉通路装置的需求。随着医疗机构采用先进的解决方案以实现有效治疗,这一趋势正在促进市场成长。此外,不断涌现的技术创新正在重塑市场格局,製造商正在开发抗菌涂层导管和微创系统等新一代产品。这些进步有助于减少併发症、提高病患舒适度并降低再入院率,从而符合高品质医疗和病人安全的理念。这正在加速全球对先进静脉通路装置的采用。
全球静脉通路装置市场驱动因素
癌症、肾臟病和心血管疾病等慢性疾病的日益普及是推动全球静脉通路装置市场扩张的关键因素。这些疾病需要长期治疗,例如化疗、透析和静脉输液。随着患者群体的不断扩大,医疗专业人员越来越倾向于使用创新静脉通路装置,以提供有效的治疗、提高患者安全并最大限度地减少手术併发症。这一趋势反映了人们对能够应对慢性疾病管理复杂性的可靠医疗解决方案日益增长的需求,并凸显了静脉通路装置在现代医疗保健中的关键作用。
限制全球静脉通路装置市场的因素
全球静脉通路装置市场面临许多限制因素,包括感染疾病、血栓症和导管功能障碍等併发症,即便在设计创新方面不断改进,这些问题仍然可能发生。这些问题常常引发医疗服务提供者对病人安全的担忧,以及对操作人员技能水准的质疑。此外,潜在的法律责任风险进一步加剧了这些担忧,导致医疗服务提供者在全面推广这些装置时犹豫不决。因此,这种犹豫不决影响了市场扩张,并凸显了持续培训和改善装置安全性对于增强医疗服务提供者信心和改善患者预后至关重要。
全球静脉通路装置市场趋势
全球静脉通路装置市场正呈现出向门诊和居家医疗服务显着发展的趋势,这主要得益于人们对便利、经济的医疗解决方案日益增长的需求。随着医疗系统越来越注重以病人为中心的护理,便携式、易用的静脉通路装置的应用也日益普及。这些创新装置使患者能够在舒适的家中接受静脉输液、透析和营养支持等必要治疗,从而最大限度地减少住院次数和相关医疗费用。这种转变不仅提升了患者的便利性,也加速了血管通路技术在全球的应用,为更便利的医疗保健铺平了道路。
Global Vascular Access Device Market size was valued at USD 9.28 Billion in 2024 and is poised to grow from USD 9.78 Billion in 2025 to USD 14.89 Billion by 2033, growing at a CAGR of 5.4% during the forecast period (2026-2033).
The Global Vascular Access Device Market is primarily driven by the increasing prevalence of chronic diseases such as cancer, diabetes, kidney disorders, and cardiovascular issues, which necessitate long-term treatment solutions like chemotherapy or dialysis. As populations age and lifestyles contribute to rising chronic illness rates, the demand for durable vascular access devices is intensifying. This trend propels market growth as healthcare providers adopt advanced solutions for effective treatment. Additionally, ongoing technological innovations are reshaping the market, with manufacturers developing next-generation products like antimicrobial-coated catheters and minimally invasive systems. These advancements mitigate complications, enhance patient comfort, and reduce hospital readmission rates, aligning with the focus on quality care and patient safety, thereby accelerating the adoption of sophisticated vascular access devices globally.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Access Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Vascular Access Device Market Segments Analysis
Global Vascular Access Device Market is segmented by Product, End Use and region. Based on Product, the market is segmented into Short Peripheral Intravenous Catheter, Huber Needles, Midline Catheters, Peripherally Inserted Central Catheter (PICCs), Central Venous Catheter (CVCs), Dialysis Catheters and Implantable Ports. Based on End Use, the market is segmented into Hospitals, Ambulatory care centers and Other end use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Vascular Access Device Market
The rise in prevalence of chronic diseases like cancer, kidney disorders, and cardiovascular issues is a significant factor propelling the expansion of the global vascular access device market. These illnesses necessitate prolonged treatment options such as chemotherapy, dialysis, and intravenous therapies. As the patient population expands, healthcare professionals are increasingly turning to innovative vascular access devices to facilitate effective treatment delivery, enhance patient safety, and minimize complications during procedures. This trend reflects a growing demand for reliable medical solutions that cater to the complexities of managing chronic health conditions and underscores the vital role of vascular access devices in contemporary healthcare.
Restraints in the Global Vascular Access Device Market
The Global Vascular Access Device market faces significant restraints due to various complications that can arise despite innovations in design, including infections, thrombosis, and catheter malfunctions. These issues often lead to apprehension among healthcare providers regarding patient safety and the requirement for skilled professionals to perform insertions. Moreover, the potential for legal liabilities further exacerbates these concerns, resulting in a reluctance to fully embrace these devices. Consequently, such hesitations impact market expansion and highlight the critical need for ongoing training and enhancements in device safety to foster confidence among healthcare practitioners and improve patient outcomes.
Market Trends of the Global Vascular Access Device Market
The Global Vascular Access Device market is witnessing a significant trend toward outpatient and home healthcare services, propelled by a rising demand for convenient and cost-effective medical solutions. As healthcare systems increasingly prioritize patient-centric care, the adoption of portable and user-friendly vascular access devices is on the rise. These innovations facilitate essential treatments such as intravenous therapies, dialysis, and nutritional support within the comfort of patients' homes, thereby minimizing hospital visits and associated healthcare costs. This shift not only enhances patient convenience but also drives the broader acceptance of vascular access technologies worldwide, paving the way for a more accessible healthcare landscape.